These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7861406)

  • 1. IAM chromatography: an in vitro screen for predicting drug membrane permeability.
    Pidgeon C; Ong S; Liu H; Qiu X; Pidgeon M; Dantzig AH; Munroe J; Hornback WJ; Kasher JS; Glunz L
    J Med Chem; 1995 Feb; 38(4):590-4. PubMed ID: 7861406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immobilized-artificial-membrane chromatography: measurements of membrane partition coefficient and predicting drug membrane permeability.
    Ong S; Liu H; Pidgeon C
    J Chromatogr A; 1996 Mar; 728(1-2):113-28. PubMed ID: 8673230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of immobilized artificial membrane chromatography to predict human oral absorption.
    Tsopelas F; Vallianatou T; Tsantili-Kakoulidou A
    Eur J Pharm Sci; 2016 Jan; 81():82-93. PubMed ID: 26485055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Caco-2 permeability of drugs using immobilized artificial membrane chromatography and physicochemical descriptors.
    Chan EC; Tan WL; Ho PC; Fang LJ
    J Chromatogr A; 2005 Apr; 1072(2):159-68. PubMed ID: 15887485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention behavior of flavonoids on immobilized artificial membrane chromatography and correlation with cell-based permeability.
    Tsopelas F; Tsagkrasouli M; Poursanidis P; Pitsaki M; Vasios G; Danias P; Panderi I; Tsantili-Kakoulidou A; Giaginis C
    Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 29044623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for absorption screening in drug discovery and development.
    Bohets H; Annaert P; Mannens G; Van Beijsterveldt L; Anciaux K; Verboven P; Meuldermans W; Lavrijsen K
    Curr Top Med Chem; 2001 Nov; 1(5):367-83. PubMed ID: 11899103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipid-based Immobilized Artificial Membrane (IAM) Chromatography: A Powerful Tool to Model Drug Distribution Processes.
    Sobanska AW; Brzezinska E
    Curr Pharm Des; 2017; 23(44):6784-6794. PubMed ID: 29046146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting human drug pharmacokinetics from in vitro permeability using an absorption-disposition model.
    Fliszar KA; Hill BT; Foster N
    J Pharm Sci; 2007 Aug; 96(8):2161-70. PubMed ID: 17387695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatographic estimation of drug disposition properties by means of immobilized artificial membranes (IAM) and C18 columns.
    Lázaro E; Ràfols C; Abraham MH; Rosés M
    J Med Chem; 2006 Aug; 49(16):4861-70. PubMed ID: 16884298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in immobilized artificial membrane (IAM) chromatography for novel drug discovery.
    Tsopelas F; Vallianatou T; Tsantili-Kakoulidou A
    Expert Opin Drug Discov; 2016; 11(5):473-88. PubMed ID: 26966996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs.
    Kotecha J; Shah S; Rathod I; Subbaiah G
    Int J Pharm; 2007 Mar; 333(1-2):127-35. PubMed ID: 17095172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
    Usansky HH; Sinko PJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the absorption of new pharmaceuticals.
    Hidalgo IJ
    Curr Top Med Chem; 2001 Nov; 1(5):385-401. PubMed ID: 11899104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane partition coefficients chromatographically measured using immobilized artificial membrane surfaces.
    Ong S; Liu H; Qiu X; Bhat G; Pidgeon C
    Anal Chem; 1995 Feb; 67(4):755-62. PubMed ID: 7702190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polar interactions drug/phospholipids estimated by IAM-HPLC vs cultured cell line passage data: Their relationships and comparison of their effectiveness in predicting drug human intestinal absorption.
    Grumetto L; Russo G; Barbato F
    Int J Pharm; 2016 Mar; 500(1-2):275-90. PubMed ID: 26780120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the intrinsic membrane permeability of Caco-2/MDCK cells by the solubility-diffusion model.
    Dahley C; Böckmann T; Ebert A; Goss KU
    Eur J Pharm Sci; 2024 Apr; 195():106720. PubMed ID: 38311258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orthogonal chromatographic descriptors for modelling Caco-2 drug permeability.
    Deconinck E; Verstraete T; Van Gyseghem E; Vander Heyden Y; Coomans D
    J Chromatogr Sci; 2012 Mar; 50(3):175-83. PubMed ID: 22337793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrophobicity of HIV protease inhibitors by immobilized artificial membrane chromatography: application and significance to drug transport.
    Stewart BH; Chung FY; Tait B; Blankley CJ; Chan OH
    Pharm Res; 1998 Sep; 15(9):1401-6. PubMed ID: 9755892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of the Caco-2 permeability assay to screen drug compounds for intestinal absorption and efflux.
    Press B
    Methods Mol Biol; 2011; 763():139-54. PubMed ID: 21874449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in parallel artificial membrane permeability assay and its applications].
    Wu YF; Liu H; Ni JM
    Yao Xue Xue Bao; 2011 Aug; 46(8):890-5. PubMed ID: 22007511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.